Expression of <i>Cyp2c/Cyp2j</i> subfamily members and oxylipin levels during LPS‐induced inflammation and resolution in mice

Wiley - Tập 33 Số 12 - Trang 14784-14797 - 2019
Joan P. Graves1, J. Alyce Bradbury1, Artiom Gruzdev1, Hong Li1, Caroline Duval1, Fred B. Lih1, Matthew L. Edin1, Darryl C. Zeldin1
1Division of Intramural Research National Institute of Environmental Health Sciences National Institutes of Health Research Triangle Park North Carolina USA

Tóm tắt

Inflammatory stimuli, such as bacterial LPS, alter the expression of many cytochromes P450. CYP2C and CYP2J subfamily members actively metabolize fatty acids to bioactive eicosanoids, which exhibit potent anti‐inflammatory effects. Herein, we examined mRNA levels of the 15 mouse Cyp2c and 7 mouse Cyp2j isoforms in liver, kidney, duodenum, and brain over a 96‐h time course of LPS‐induced inflammation and resolution. Plasma and liver eicosanoid levels were also measured by liquid chromatography with tandem mass spectrometry. Expression changes in Cyp2c and Cyp2j isoforms were both isoform and tissue specific. Total liver Cyp2c and Cyp2j mRNA content was reduced by 80% 24 h after LPS but recovered to baseline levels by 96 h. Total Cyp2c and Cyp2j mRNA in kidney (‐19%) and duodenum (‐64%) were reduced 24 h after LPS but recovered above baseline by 72 h. Total Cyp2c and Cyp2j mRNA content in brain was elevated at all time points after LPS dosing. Plasma eicosanoids transiently increased 3‐6 h after administration of LPS. In liver, esterified oxylipin levels decreased during acute inflammation and before recovering. The biphasic suppression and recovery of mouse Cyp2c and Cyp2j isoforms and associated changes in eicosanoid levels during LPS‐induced inflammation and resolution may have important physiologic consequences.—Graves, J. P., Bradbury, J. A., Gruzdev, A., Li, H., Duval, C., Lih, F. B., Edin, M. L., Zeldin, D. C. Expression of Cyp2c/Cyp2j subfamily members and oxylipin levels during LPS‐induced inflammation and resolution in mice. FASEB J. 33, 14784‐14797 (2019). www.fasebj.org

Từ khóa


Tài liệu tham khảo

10.1097/00041433-200206000-00007

10.1016/S0140-6736(02)11203-7

10.1097/00008571-199602000-00002

10.1016/S0022-2275(20)32049-6

10.1016/bs.apha.2016.04.003

10.1074/jbc.RA117.000298

10.1016/j.ijmm.2007.04.001

10.1016/j.cyto.2008.01.006

10.1038/emm.2013.97

10.1124/jpet.103.057174

10.1124/dmd.110.035287

10.1126/science.285.5431.1276

10.1096/fj.10-171488

10.1016/j.prostaglandins.2013.02.003

10.1124/dmd.117.075697

10.1124/dmd.115.064139

10.1007/s10620-012-2217-1

10.1038/nrd2875

10.1006/meth.2001.1262

10.1289/EHP316

10.1214/aoms/1177729885

10.1677/jme.0.0250169

10.1007/978-3-642-59524-0_3

10.1186/s12929-017-0370-8

10.3109/03602539709002246

Morgan E. T., 2001, Regulation of cytochrome p450 by inflammatory mediators: why and how?, Drug Metab. Dispos., 29, 207

10.1248/bpb.35.473

10.1124/dmd.107.018747

10.1016/j.trci.2018.06.014

10.1016/j.nbd.2009.11.004

10.1016/S0165-6147(03)00176-7

10.1073/pnas.1819234116

10.1016/j.bbrc.2014.03.020

10.1124/jpet.111.189597

10.1186/s13028-014-0069-8

10.1016/S0006-2952(02)01393-X

10.1073/pnas.0503279102

10.1074/jbc.M509352200

10.1016/j.bbalip.2009.02.002

10.1074/jbc.M110.118406

10.1016/j.abb.2008.01.002

10.1073/pnas.1705615114

10.1074/jbc.M113.481077

10.1152/ajpcell.00402.2006

10.1021/jm200132q

10.1016/j.bbapap.2010.09.009